DK3615511T3 - Lipopeptidforbindelser til behandling af smertelidelser - Google Patents

Lipopeptidforbindelser til behandling af smertelidelser Download PDF

Info

Publication number
DK3615511T3
DK3615511T3 DK18719204.2T DK18719204T DK3615511T3 DK 3615511 T3 DK3615511 T3 DK 3615511T3 DK 18719204 T DK18719204 T DK 18719204T DK 3615511 T3 DK3615511 T3 DK 3615511T3
Authority
DK
Denmark
Prior art keywords
treatment
pain disorders
lipopeptide compounds
lipopeptide
compounds
Prior art date
Application number
DK18719204.2T
Other languages
English (en)
Inventor
Nicolas Cenac
Justine Bertrand-Michel
Teresa Perez-Berezo
Thierry Durand
Jean-Marie Galano
Julien Pujo
Eric Oswald
Patricia Martin
Faouder Pauline Le
Alexandre Guy
Original Assignee
Inst Nat Sante Rech Med
Univ Toulouse 3 Paul Sabatier
Centre Nat Rech Scient
Ct Hospitalier Universitaire Toulouse
Ecole Nat Veterinaire De Toulouse
Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement
Univ Montpellier
Enscm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Univ Toulouse 3 Paul Sabatier, Centre Nat Rech Scient, Ct Hospitalier Universitaire Toulouse, Ecole Nat Veterinaire De Toulouse, Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement, Univ Montpellier, Enscm filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK3615511T3 publication Critical patent/DK3615511T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK18719204.2T 2017-04-28 2018-04-27 Lipopeptidforbindelser til behandling af smertelidelser DK3615511T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17305481 2017-04-28
PCT/EP2018/060873 WO2018197666A1 (en) 2017-04-28 2018-04-27 Lipopeptide compounds for the treatment of pain disorders

Publications (1)

Publication Number Publication Date
DK3615511T3 true DK3615511T3 (da) 2022-10-03

Family

ID=58707441

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18719204.2T DK3615511T3 (da) 2017-04-28 2018-04-27 Lipopeptidforbindelser til behandling af smertelidelser

Country Status (5)

Country Link
US (1) US11912645B2 (da)
EP (1) EP3615511B1 (da)
DK (1) DK3615511T3 (da)
ES (1) ES2928425T3 (da)
WO (1) WO2018197666A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7590401B2 (ja) * 2019-07-08 2024-11-26 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 改変されたescherichia coli株nissle及び胃腸障害の処置
EP4507686A1 (en) 2022-04-15 2025-02-19 Institut National de la Santé et de la Recherche Médicale Lipopeptide compound and treatment of pain disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010109284A1 (en) 2009-03-27 2010-09-30 University Of Manitoba Antimicrobial cationic lipo-beta-peptides

Also Published As

Publication number Publication date
EP3615511A1 (en) 2020-03-04
US11912645B2 (en) 2024-02-27
EP3615511B1 (en) 2022-07-13
ES2928425T3 (es) 2022-11-17
WO2018197666A1 (en) 2018-11-01
US20200048187A1 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
DK3570844T3 (da) Azolopyrimidin til behandlingen af kræftrelaterede lidelser
DK3501542T3 (da) Esketamin til behandling af depression
DK3743070T3 (da) Forbindelser til behandling af kinaseafhængige lidelser
DK3728271T3 (da) Makrocykliske forbindelser til behandling af sygdomme
DK3785733T3 (da) Farmaceutisk sammensætning til behandling af autisme
DK3347030T3 (da) Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
DK3326641T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3143025T3 (da) Forbindelser til behandling af spinal muskelatrofi
DK3185876T3 (da) Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
DK3936130T3 (da) Doseringsskema for Valbenazin til behandling af hyperkinetiske bevægelsesforstyrrelser
DK3439635T3 (da) Formuleringer til behandling af fast tumor
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3504187T3 (da) Anvendelse af pridopidin til behandling af funktionel tilbagegang
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3503890T3 (da) Anvendelse af pridopidin til behandling af dystonier
DK3609529T3 (da) Rna til behandling af autoimmune sygdomme
DK3498278T3 (da) Forbindelser til behandling af sygdomme relateret til DUX4-ekspression
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
DK3724173T3 (da) Forbindelser til behandling af neuromuskulære lidelser
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
DK3439661T3 (da) Fremgangsmåder til behandling af øjenlidelser
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer
EP3655036C0 (en) COMPOSITIONS FOR THE TREATMENT OF STRESS-RELATED DISORDERS
DK3585808T3 (da) Modificerede serpiner til behandlingen af bradykinin formidlet sygdom
DK3638293T5 (da) Sammensætninger til behandling af cancer